Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: June 17, 2009

Drug Name	Review Type	Class	Manufacturer
Texacort	New Drug Initial Review	Topical Corticosteroid	JSJ
CNL8 Nail Kit	New Drug Initial Review	Topical Antifungal	JSJ
Flector Patch	New Drug Initial Review	Topical NSAID	King
Kapidex	New Drug Initial Review	Proton Pump Inhibitor	Takeda
Cinryze	New Drug Initial Review	Hereditary Angioedema	ViroPharm
Banzel	New Drug Initial Review	Anticonvulsant	Eisai
Vimpat	New Drug Initial Review	Anticonvulsant	UCB
Durezol	New Drug Initial Review	Ophthalmic- Anti-Inflammatory	Sirion
Aplenzin	New Drug Initial Review	Antidepressants - Other	Sanofi
Simponi	New Drug Initial Review	Biologic Modifier	Centocor
Zanaflex Caps	New Drug Initial Review	Skeletal Muscle Relaxant	Acorda
Rapaflo	New Drug Initial Review	BPH Agent	Watson
Gelnique Gel	New Drug Initial Review	Urinary Anti-Incontinence Agent	Watson
Equetro	New Drug Appeal	Bipolar I Disorder	Validus
Zemplar	New Drug Appeal	Hyperparathyroidism due to CKD	Abbott
Trilipix	New Drug Appeal	Lipotropics - Other	Abbott
Simcor	New Drug Appeal	Lipotropics- Statins & Combinations	Abbott
Vigamox	PDL Appeal	Ophthalmic - Antibiotics	Alcon

Footer